| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Fazlul H. Sarkar | Q56648717 |
| P2093 | author name string | Yiwei Li | |
| Sanjeev Banerjee | |||
| P2860 | cites work | Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours | Q28206040 |
| Cancer chemopreventive activity of resveratrol, a natural product derived from grapes | Q28300555 | ||
| Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes | Q28307762 | ||
| Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA | Q28371975 | ||
| Nuclear factor-kappaB in cancer development and progression | Q29547879 | ||
| Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis | Q29614405 | ||
| Cancer statistics, 2006 | Q29615133 | ||
| Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer | Q46902076 | ||
| Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts | Q46941754 | ||
| Mitogenic and antiapoptotic role of constitutive NF-kappaB/Rel activity in pancreatic cancer | Q47887187 | ||
| Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells. | Q53631737 | ||
| The Notch signaling pathway is related to neurovascular progression of pancreatic cancer. | Q54628566 | ||
| Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells | Q56749698 | ||
| Modulation of pancreatic carcinogenesis by antioxidants | Q73132219 | ||
| Abrogation of the Rb/p16 tumor-suppressive pathway in virtually all pancreatic carcinomas | Q73555144 | ||
| Notch mediates TGF alpha-induced changes in epithelial differentiation during pancreatic tumorigenesis | Q73614651 | ||
| Epidermal growth factor receptor blockade with C225 plus gemcitabine results in regression of human pancreatic carcinoma growing orthotopically in nude mice by antiangiogenic mechanisms | Q73803447 | ||
| Overexpression of cyclooxygenase-2 in carcinoma of the pancreas | Q78206842 | ||
| Dietary intake of lycopene is associated with reduced pancreatic cancer risk | Q81448492 | ||
| Down-regulation of notch-1 inhibits invasion by inactivation of nuclear factor-kappaB, vascular endothelial growth factor, and matrix metalloproteinase-9 in pancreatic cancer cells | Q82698906 | ||
| Molecular pathogenesis of pancreatic cancer | Q82888824 | ||
| Molecular analysis of the p53 gene in pancreatic adenocarcinoma | Q30430851 | ||
| Suppression of human pancreatic carcinoma cell growth and invasion by epigallocatechin-3-gallate | Q31097458 | ||
| Cetuximab, a monoclonal antibody targeting the epidermal growth factor receptor, in combination with gemcitabine for advanced pancreatic cancer: a multicenter phase II Trial | Q33361488 | ||
| Green tea in chemoprevention of cancer | Q33814275 | ||
| Inactivation of nuclear factor kappaB by soy isoflavone genistein contributes to increased apoptosis induced by chemotherapeutic agents in human cancer cells | Q34439326 | ||
| Molecular prognostic markers in pancreatic cancer: a systematic review | Q34560651 | ||
| Vitamin D intake and the risk for pancreatic cancer in two cohort studies | Q34567226 | ||
| The genetics of pancreatic cancer. | Q35208669 | ||
| Indole-3-carbinol and prostate cancer | Q35966641 | ||
| Recent advances on the molecular mechanisms involved in pancreatic cancer progression and therapies | Q36300992 | ||
| A review of erlotinib and its clinical use. | Q36376408 | ||
| Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. | Q36410856 | ||
| Gene therapy developments for pancreatic cancer | Q36426211 | ||
| Molecular biomarkers: their increasing role in the diagnosis, characterization, and therapy guidance in pancreatic cancer. | Q36464111 | ||
| Clinical implications of the mechanism of epidermal growth factor receptor inhibitors | Q36565941 | ||
| Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications | Q36581391 | ||
| Inhibition of basal and mitogen-stimulated pancreatic cancer cell growth by cyclin D1 antisense is associated with loss of tumorigenicity and potentiation of cytotoxicity to cisplatinum | Q37377431 | ||
| Gene therapy based on gemcitabine chemosensitization suppresses pancreatic tumor growth. | Q40227847 | ||
| Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer | Q40248519 | ||
| Nuclear factor-kappaB contributes to hedgehog signaling pathway activation through sonic hedgehog induction in pancreatic cancer | Q40254051 | ||
| Antitumor and antimetastatic activities of docetaxel are enhanced by genistein through regulation of osteoprotegerin/receptor activator of nuclear factor-kappaB (RANK)/RANK ligand/MMP-9 signaling in prostate cancer | Q40284981 | ||
| Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer | Q40365695 | ||
| Overexpression of cyclin D1 promotes tumor cell growth and confers resistance to cisplatin-mediated apoptosis in an elastase-myc transgene-expressing pancreatic tumor cell line | Q40382268 | ||
| Potentiation of the radiation effect with genistein in cervical cancer cells | Q40387923 | ||
| Epidermal growth factor receptor-related protein inhibits cell growth and induces apoptosis of BxPC3 pancreatic cancer cells | Q40427648 | ||
| Genistein, a soy isoflavone, enhances necrotic-like cell death in a breast cancer cell treated with a chemotherapeutic agent. | Q40462950 | ||
| Inhibition of nuclear translocation of nuclear factor-{kappa}B contributes to 3,3'-diindolylmethane-induced apoptosis in breast cancer cells. | Q40467145 | ||
| Selective growth regulatory and pro-apoptotic effects of DIM is mediated by AKT and NF-kappaB pathways in prostate cancer cells | Q40485942 | ||
| Cyclooxygenase-2-dependent and -independent effects of celecoxib in pancreatic cancer cell lines | Q40492311 | ||
| Nuclear factor-kappaB and IkappaB kinase are constitutively active in human pancreatic cells, and their down-regulation by curcumin (diferuloylmethane) is associated with the suppression of proliferation and the induction of apoptosis | Q40505601 | ||
| Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line | Q40564629 | ||
| Inhibition of AKT abrogates chemotherapy-induced NF-kappaB survival mechanisms: implications for therapy in pancreatic cancer | Q40572213 | ||
| PSK-mediated NF-kappaB inhibition augments docetaxel-induced apoptosis in human pancreatic cancer cells NOR-P1. | Q40657105 | ||
| Function of nuclear factor kappaB in pancreatic cancer metastasis | Q40676051 | ||
| Chemopreventive effects of tea extracts and various components on human pancreatic and prostate tumor cells in vitro | Q40907965 | ||
| Indole-3-carbinol and tamoxifen cooperate to arrest the cell cycle of MCF-7 human breast cancer cells. | Q40964260 | ||
| Usage of the NF-kappaB inhibitor sulfasalazine as sensitizing agent in combined chemotherapy of pancreatic cancer | Q42437041 | ||
| Resveratrol inhibits proliferation and induces apoptosis in human pancreatic cancer cells | Q44200538 | ||
| Modulation of the constitutive activated STAT3 transcription factor in pancreatic cancer prevention: effects of indole-3-carbinol (I3C) and genistein. | Q44796219 | ||
| Celecoxib inhibits vascular endothelial growth factor expression in and reduces angiogenesis and metastasis of human pancreatic cancer via suppression of Sp1 transcription factor activity | Q44802879 | ||
| Pilot study of celecoxib and infusional 5-fluorouracil as second-line treatment for advanced pancreatic carcinoma | Q44955215 | ||
| Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells | Q45083945 | ||
| Sensitization of taxol-induced apoptosis by curcumin involves down-regulation of nuclear factor-kappaB and the serine/threonine kinase Akt and is independent of tubulin polymerization | Q45182288 | ||
| Epigallocatechin-3-gallate induces mitochondrial membrane depolarization and caspase-dependent apoptosis in pancreatic cancer cells | Q45261084 | ||
| Inhibition of integrin-linked kinase by a selective small molecule inhibitor, QLT0254, inhibits the PI3K/PKB/mTOR, Stat3, and FKHR pathways and tumor growth, and enhances gemcitabine-induced apoptosis in human orthotopic primary pancreatic cancer xe | Q45285589 | ||
| Nutritional factors and risk of pancreatic cancer: a population-based case-control study based on direct interview in Japan | Q46437656 | ||
| Inhibition of nuclear factor kappab activity by genistein is mediated via Notch-1 signaling pathway in pancreatic cancer cells | Q46801606 | ||
| Erlotinib and chemoradiation followed by maintenance erlotinib for locally advanced pancreatic cancer: a phase I study | Q46827306 | ||
| 3,3'-diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5. | Q46839472 | ||
| Peritumoral injection of adenovirus vector expressing NK4 combined with gemcitabine treatment suppresses growth and metastasis of human pancreatic cancer cells implanted orthotopically in nude mice and prolongs survival | Q46845221 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | pancreatic cancer | Q212961 |
| pathogenesis | Q372016 | ||
| prevention | Q1717246 | ||
| P304 | page(s) | 326-36 | |
| P577 | publication date | 2007-11-01 | |
| P1433 | published in | Toxicology and Applied Pharmacology | Q2446974 |
| P1476 | title | Pancreatic cancer: pathogenesis, prevention and treatment | |
| P478 | volume | 224 |
| Q37790673 | Advances in pancreatic cancer detection |
| Q38717006 | Anticancer Activity of Punica granatum (Pomegranate): A Review. |
| Q34447152 | Application of chitosan-based nanocarriers in tumor-targeted drug delivery. |
| Q44623273 | Assessment of soluble angiogenic markers in pancreatic cancer. |
| Q38089821 | Biomarkers in the diagnosis and early detection of pancreatic cancer |
| Q44221301 | Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells |
| Q49907239 | CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species |
| Q58652240 | Cancer Therapy Based on Nanomaterials and Nanocarrier Systems |
| Q36642898 | Chemoprevention of pancreatic cancer using solid-lipid nanoparticulate delivery of a novel aspirin, curcumin and sulforaphane drug combination regimen |
| Q84966111 | Clinical significance of ephrin (eph)-A1, -A2, -a4, -a5 and -a7 receptors in pancreatic ductal adenocarcinoma |
| Q29248618 | Current applications and future prospects of nanomaterials in tumor therapy |
| Q59228035 | Dextrin and poly(lactide)-based biocompatible and biodegradable nanogel for cancer targeted delivery of doxorubicin hydrochloride |
| Q34658072 | Diet and supplements and their impact on colorectal cancer |
| Q46360353 | Effect of soybean oil on atherogenic metabolic risks associated with estrogen deficiency in ovariectomized rats: dietary soybean oil modulate atherogenic risks in overiectomized rats |
| Q30477815 | Experimental ablation of the pancreas with high intensity focused ultrasound (HIFU) in a porcine model. |
| Q31066570 | Gene expression profile analysis of pancreatic cancer based on microarray data |
| Q35145009 | Genomic analysis of drug resistant pancreatic cancer cell line by combining long non-coding RNA and mRNA expression profling |
| Q38196813 | Histamine and histamine receptor regulation of gastrointestinal cancers |
| Q37084377 | Hyperglycemia Promotes the Epithelial-Mesenchymal Transition of Pancreatic Cancer via Hydrogen Peroxide |
| Q36062094 | Identification of disease-associated pathways in pancreatic cancer by integrating genome-wide association study and gene expression data |
| Q38450835 | Identification of genes and pathways associated with pancreatic ductal adenocarcinoma by bioinformatics analyses |
| Q57127188 | Identification of key microRNAs and their targets in exosomes of pancreatic cancer using bioinformatics analysis |
| Q47155278 | Identification of potential prognostic ceRNA module biomarkers in patients with pancreatic adenocarcinoma |
| Q33891498 | In vitro antiproliferative activity of partially purified Trigona laeviceps propolis from Thailand on human cancer cell lines |
| Q89081796 | In vitro antiproliferative and apoptosis-inducing activities of crude ethyle alcohole extract of Quercus brantii L. acorn and subsequent fractions |
| Q43184695 | Investigation of Astragalus honey and propolis extract's cytotoxic effect on two human cancer cell lines and their oncogen and proapoptotic gene expression profiles |
| Q38289532 | Lessons from Nature: Sources and Strategies for Developing AMPK Activators for Cancer Chemotherapeutics |
| Q34496697 | Ligand stimulation of ErbB4 and a constitutively-active ErbB4 mutant result in different biological responses in human pancreatic tumor cell lines. |
| Q36326344 | MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. |
| Q24630097 | MicroRNAs in NF-kappaB signaling |
| Q37492447 | Novel dual cyclooxygenase and lipoxygenase inhibitors targeting hyaluronan-CD44v6 pathway and inducing cytotoxicity in colon cancer cells |
| Q24564267 | Novel therapeutic targets for pancreatic cancer |
| Q33599115 | Optimized construction of MUC1-VNTRn DNA vaccine and its anti-pancreatic cancer efficacy |
| Q53502200 | Overexpressions of DLL4 and CD105 are Associated with Poor Prognosis of Patients with Pancreatic Ductal Adenocarcinoma. |
| Q40489308 | Overexpressions of miR-212 are associated with poor prognosis of patients with pancreatic ductal adenocarcinoma. |
| Q38994024 | PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines |
| Q34027390 | PROFESS: a PROtein function, evolution, structure and sequence database |
| Q33857806 | Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway |
| Q34979334 | Structure-activity studies on therapeutic potential of Thymoquinone analogs in pancreatic cancer |
| Q93015111 | Study of anticancer, antimicrobial, immunomodulatory, and silver nanoparticles production by Sidr honey from three different sources |
| Q36004784 | Synergistic effect of garcinol and curcumin on antiproliferative and apoptotic activity in pancreatic cancer cells |
| Q34332428 | Synthetic triterpenoids prolong survival in a transgenic mouse model of pancreatic cancer. |
| Q37730861 | Targeting Notch signaling in pancreatic cancer |
| Q39779735 | Trigona laeviceps propolis from Thailand: antimicrobial, antiproliferative and cytotoxic activities |
| Q33375215 | Triphala inhibits both in vitro and in vivo xenograft growth of pancreatic tumor cells by inducing apoptosis |
| Q38477847 | Uncovering the pathogenesis and identifying novel targets of pancreatic cancer using bioinformatics approach |
Search more.